Clarivate (NYSE:CLVT) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Clarivate (NYSE:CLVT) released its quarterly earnings results on Tuesday. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04, FiscalAI reports. The company had revenue of $617.00 million during the quarter, compared to the consensus estimate of $604.79 million. Clarivate had a negative net margin of 15.83% and a positive return on equity of 8.55%. Clarivate updated its FY 2026 guidance to 0.700-0.800 EPS.

Clarivate Trading Down 5.4%

Clarivate stock opened at $1.68 on Tuesday. Clarivate has a 12 month low of $1.66 and a 12 month high of $4.91. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of -2.94 and a beta of 1.51. The business’s fifty day simple moving average is $2.82 and its two-hundred day simple moving average is $3.48. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 0.90.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Morgan Stanley reissued an “underweight” rating and issued a $3.00 target price (down previously from $5.00) on shares of Clarivate in a research report on Wednesday, December 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Monday, December 29th. The Goldman Sachs Group downgraded Clarivate from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $4.20 to $3.60 in a report on Thursday, January 8th. Finally, Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Three research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clarivate presently has a consensus rating of “Reduce” and a consensus price target of $3.70.

Insider Activity

In other news, insider Bar Veinstein sold 309,902 shares of Clarivate stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $3.74, for a total value of $1,159,033.48. Following the completion of the transaction, the insider owned 848,811 shares of the company’s stock, valued at $3,174,553.14. The trade was a 26.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 23.18% of the stock is currently owned by corporate insiders.

Institutional Trading of Clarivate

A number of institutional investors and hedge funds have recently bought and sold shares of CLVT. Jump Financial LLC bought a new position in shares of Clarivate in the fourth quarter worth approximately $41,000. PharVision Advisers LLC purchased a new position in Clarivate in the 3rd quarter worth approximately $45,000. Pitcairn Co. bought a new position in Clarivate in the 2nd quarter valued at approximately $52,000. RPO LLC bought a new position in Clarivate in the 4th quarter valued at approximately $64,000. Finally, Corsair Capital Management L.P. purchased a new stake in Clarivate during the 4th quarter valued at $67,000. 85.72% of the stock is currently owned by institutional investors.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.